TREM2 and Alzheimer’s: A Reassessment After INVOKE-2
Table of Contents
Exploring the future of Alzheimer’s treatment strategies following a significant clinical trial setback.
A recent study published in Nature Medicine is prompting a re-evaluation of TREM2 (Triggering Receptor Expressed on Myeloid cells 2) as a therapeutic target for Alzheimer’s disease. The reassessment follows the failure of the INVOKE-2 trial, a clinical study designed to assess the efficacy of a TREM2-activating antibody in slowing the progression of the disease. The original publication appeared online on 02 July 2025 (Two: 10.1038/S41591-025-03816-2).
Understanding TREM2’s Role in Alzheimer’s
TREM2 is a protein expressed on immune cells in the brain,particularly microglia. It plays a crucial role in clearing amyloid plaques, one of the hallmarks of Alzheimer’s disease, and in modulating neuroinflammation. Genetic studies have previously linked mutations in the TREM2 gene to an increased risk of developing Alzheimer’s, suggesting that enhancing TREM2 function could be a potential therapeutic strategy.
“TREM2 plays a crucial role in clearing amyloid plaques…and in modulating neuroinflammation.”
The INVOKE-2 Trial: A Disappointing Outcome
The INVOKE-2 trial aimed to boost TREM2 activity using a novel antibody. while the approach showed promise in preclinical studies,the clinical trial failed to demonstrate a significant benefit in patients with early-stage Alzheimer’s disease. This setback has led researchers to question the initial assumptions about TREM2 and its role in the complex pathology of Alzheimer’s.
Frequently Asked Questions About Alzheimer’s Disease
- What are the early signs of Alzheimer’s disease?
- early signs can include memory loss that disrupts daily life, challenges in planning or solving problems, confusion with time or place, and changes in mood or personality.
- Is there a cure for Alzheimer’s disease?
- Currently, there is no cure for Alzheimer’s disease, but there are treatments that can definitely help manage symptoms and improve quality of life.
- What are the risk factors for Alzheimer’s disease?
- Risk factors include age, family history, genetics, and lifestyle factors such as diet and exercise.
- How is Alzheimer’s disease diagnosed?
- Diagnosis typically involves a combination of medical history,physical and neurological exams,cognitive tests,and brain imaging.
Sources
- Alzheimer’s Association: 2023 Alzheimer’s Disease Facts and Figures
- National Institute on Aging: What Is Alzheimer’s Disease?
- Centers for Disease Control and Prevention: Alzheimer’s Disease
- Alzheimer’s Association: Facts and Figures
- National Center for Health Statistics: Alzheimer’s Disease
- World Health Institution: Dementia
